Medtech


May 28, 2026

INSP: Noridian’s Modifier & Service Date Inconsistencies

By John Leppard

With Noridian (17% of services) including instructions that physicians bill for Inspire Medical’s (INSP) Inspire V procedure with a -52 (reduced work / payment) modifier this morning, following a similar update from WPS on May…

Read More >>

May 26, 2026

GKOS: iDose LCD & Laser Headwinds

By John Leppard

Following last week’s draft LCDs requiring Glaukos (GKOS) iDose patients to first fail ≥ 2 topical medications and selective laser trabeculoplasty (SLT), the absence of reliable data on the proportion of existing patients that can…

Read More >>

May 21, 2026

GKOS: iDose Coverage & Second Line Therapy

By John Leppard

The draft local coverage decision (LCD) issued today by five MACs with jurisdiction over ~70% of Glaukos (GKOS) Medicare FFS volumes is both better and worse than we had anticipated for the company’s growing iDose…

Read More >>

May 15, 2026

INSP: New Code Denial & Implications

By John Leppard

With today’s rejection of INSP’s coding application for the Inspire V device by the AMA, the company’s last opportunity to have a new code take effect by Jan. 1, 2028 will be to secure approval…

Read More >>

May 7, 2026

iRhythm (IRTC): Final LCD Signals Relief, Modest Headwind

By John Leppard

We suspect iRhythm (IRTC) faces both relief and little more than a modest growth headwind following a finalized local coverage determination (LCD) from its primary Medicare Administrative Contractor (MAC) this morning. In keeping with expectations…

Read More >>

May 7, 2026

INSP: MAC Modifier Mandate

By John Leppard

Medicare Administrative Contractor (WPS) WPS – with jurisdiction over ~13% of INSP implants – this morning updated its hypoglossal nerve LCD billing article to instruct physicians to bill for Inspire V services with a -52…

Read More >>

May 5, 2026

Inspire Medical & Messy Medicare Modifiers

By John Leppard

We view Inspire Medical’s (INSP) commentary / guidance on the risk of persistent coding and reimbursement headwinds throughout 2026 (-$120M to -$150M) as appropriately characterizing the current uncertainty, with limited prospects for near-term clarity. In…

Read More >>

April 23, 2026

RAPID Device Coverage: Rebrand or Brand New?

By John Leppard

The joint CMS / FDA press release this morning outlining the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway for breakthrough medical devices strikes us more as a rebranding of the existing transitional…

Read More >>

April 21, 2026

INSP: MAC Modifier Feedback Bolsters View

By John Leppard

Amid persistent investor questions on Medicare Administrative Contractor (MAC) billing / coding requirements for Inspire Medical’s (INSP) Inspire V device, we continue to believe that the MACs will ultimately instruct providers to use the -52…

Read More >>

April 9, 2026

Inspire Medical (INSP): More MAC Wrinkles

By John Leppard

While we view today’s update of Medicare Administrative Contractor (MAC) WPS’s billing and coding article for hypoglossal nerve stimulation (HGNS) – omitting requirements that physicians bill using a -52 (reduced work) modifier – as directionally…

Read More >>